Adial Pharmaceuticals, Inc · NASDAQ:ADIL
Adial Pharmaceuticals, Inc shareholders
As of Jun 30, 2026, 16 institutions reported holding Adial Pharmaceuticals, Inc, 5.2% of its shares. Largest: Jane Street, Citadel and StoneX Group Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Adial Pharmaceuticals, Inc | Change | Filed |
|---|---|---|---|---|
| Jane Street | 32,119 | 1.2% | new | Aug 14, 2026 |
| Citadel | 29,547 | 1.1% | new | Aug 14, 2026 |
| StoneX Group Inc. | 19,699 | 0.75% | new | Aug 12, 2026 |
| UBS | 19,147 | 0.73% | +18,605 | Aug 13, 2026 |
| Geode Capital | 12,393 | 0.47% | −11,856 | Aug 12, 2026 |
| Vanguard | 11,710 | 0.45% | +5,470 | Aug 13, 2026 |
| China Universal Asset Management Co., Ltd. | 8,000 | 0.30% | new | Jul 24, 2026 |
| Manchester Capital Management LLC | 1,923 | 0.07% | no change | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 1,419 | 0.05% | +63 | Aug 11, 2026 |
| BlackRock | 304 | 0.01% | −806 | Aug 7, 2026 |